Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 325 participants.
Also called NCT01728116
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 325 participants
- Sponsor
- Morphic Medical Inc.
- Registry
-
NCT01728116
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01728116. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2016-02 (actual). Results posted on 2016-12-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
- Acronym
- ENDO
- Condition
- Type 2 Diabetes
- Condition
- Obesity
- Intervention (Device)
- EndoBarrier
- Intervention (Procedure)
- Sham Procedure
- Lead sponsor
- Morphic Medical Inc.
Record details
- Record id
cardio:ct-nct01728116- Content hash
cd2002d8784853b1e6b813e439ac85c0a2b8c82ec1add7048f6ec399bfb5da8c